NFKB1 and cancer: Bertazza et al. revealed EF24’s competence in modulating signaling pathways pivotal in cancer progression, including NF-κB, PI3K/Akt/mTOR, and Wnt/β-catenin pathways, within adrenocortical tumor cell lines SW13 and H295R [33].